Literature DB >> 6681123

Inhibition of neutrophil phagocytosis and enzyme release by hyaluronic acid.

E J Pisko, R A Turner, L P Soderstrom, M Panetti, S L Foster, W J Treadway.   

Abstract

Hyaluronic acid at a concentration found in normal joints (4 mg/ml) inhibited the uptake of aggregated IgG by human peripheral blood polymorphonuclear leukocytes, but concentrations of hyaluronic acid found in inflammatory joints (1 mg/ml) did not. Similarly, hyaluronic acid at 4 mg/ml, but not 1 mg/ml, inhibited the release of lysozyme from aggregated IgG stimulated polymorphonuclear leukocytes. beta-Glucuronidase release was inhibited by both concentrations of hyaluronic acid. Physiological concentrations of hyaluronic acid inhibit this model system for the fluid phase of rheumatoid arthritis and hyaluronic acid may be an important immunomodulating substance in the rheumatoid joint.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6681123

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  8 in total

1.  Characterization of macrophages elicited by intraperitoneal injection of hyaluronate.

Authors:  D Ponzin; P Vecchia; G Toffano; C Giordano; A Bruni
Journal:  Agents Actions       Date:  1986-08

2.  Swelling and Mechanical Characterization of Polyelectrolyte Hydrogels as Potential Synthetic Cartilage Substitute Materials.

Authors:  Johanna Romischke; Anton Scherkus; Michael Saemann; Simone Krueger; Rainer Bader; Udo Kragl; Johanna Meyer
Journal:  Gels       Date:  2022-05-12

3.  In vitro effects of hyaluronan on prostaglandin E2 induction by interleukin-1 in rabbit articular chondrocytes.

Authors:  M Akatsuka; Y Yamamoto; K Tobetto; T Yasui; T Ando
Journal:  Agents Actions       Date:  1993-01

4.  Pentosan polysulphate and glycosaminoglycan polysulphate stimulate the synthesis of hyaluronan in vivo.

Authors:  D J Francis; N Hutadilok; P Kongtawelert; P Ghosh
Journal:  Rheumatol Int       Date:  1993       Impact factor: 2.631

5.  The potency of hyaluronan of different molecular weights in the stimulation of blood phagocytes.

Authors:  Barbora Safrankova; Silvie Gajdova; Lukas Kubala
Journal:  Mediators Inflamm       Date:  2011-02-09       Impact factor: 4.711

Review 6.  Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: mechanisms of action.

Authors:  Larry W Moreland
Journal:  Arthritis Res Ther       Date:  2003-01-14       Impact factor: 5.156

7.  Expression analysis of three isoforms of hyaluronan synthase and hyaluronidase in the synovium of knees in osteoarthritis and rheumatoid arthritis by quantitative real-time reverse transcriptase polymerase chain reaction.

Authors:  Mamoru Yoshida; Shigaku Sai; Keishi Marumo; Takaaki Tanaka; Naoki Itano; Koji Kimata; Katsuyuki Fujii
Journal:  Arthritis Res Ther       Date:  2004-09-22       Impact factor: 5.156

8.  Arthroscopic debridement of the osteoarthritic knee combined with hyaluronic acid (Orthovisc) treatment: a case series and review of the literature.

Authors:  Xinning Li; Agam Shah; Patricia Franklin; Renee Merolli; Jill Bradley; Brian Busconi
Journal:  J Orthop Surg Res       Date:  2008-09-17       Impact factor: 2.359

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.